Skip to main content

Heart Diseases: Medical Treatments

Question for Department of Health and Social Care

UIN 45250, tabled on 2 September 2022

To ask the Secretary of State for Health and Social Care, with reference to the Stickels June 2022 BMJ paper on aortic stenosis waiting times, what steps his Department plans to take to facilitate the conversion of SAVR to TAVI for aortic stenosis treatment for the purposes of expediting the recovery of the heart valve disease backlog.

Answered on

7 September 2022

The National Institute for Health and Care Excellence (NICE) makes recommendations on interventions for aortic stenosis in its guideline ‘Heart valve disease presenting in adults: investigation and management’. It has no current plans to review or update this guideline. For adults unsuited to heart valve surgery, NHS England recommends transcatheter aortic valve implantation (TAVI) to treat aortic stenosis.

We have committed £2.3 billion to launch at least 100 community diagnostic centres by 2024/25 to increase diagnostic activity and reduce waiting times for patients with heart valve disease, such as aortic stenosis. In addition, the National Health Service is investing in cardiac networks to support whole pathway improvements. These networks have been developed to take an evidence based, clinically led, whole pathway approach to improving prevention, diagnosis, treatment and end of life care.

Named day
Named day questions only occur in the House of Commons. The MP tabling the question specifies the date on which they should receive an answer. MPs may not table more than five named day questions on a single day.